Golden Throat Holdings Group Company Limited (6896.HK)
HKD 4.25
(-0.47%)
HKD 4.25
(-0.47%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 250.16 Million CNY | -11.04% |
| 2022 | 281.21 Million CNY | 49.87% |
| 2021 | 187.64 Million CNY | 21.8% |
| 2020 | 154.05 Million CNY | -8.09% |
| 2019 | 167.61 Million CNY | 64.03% |
| 2018 | 102.18 Million CNY | 66.48% |
| 2017 | 61.38 Million CNY | -40.36% |
| 2016 | 102.91 Million CNY | -33.44% |
| 2015 | 154.61 Million CNY | 26.85% |
| 2014 | 121.89 Million CNY | 74.34% |
| 2013 | 69.91 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q4 | 128.01 Million CNY | 4.81% |
| 2023 FY | 250.16 Million CNY | -11.04% |
| 2023 Q2 | 122.14 Million CNY | -45.59% |
| 2022 Q4 | 224.48 Million CNY | 295.7% |
| 2022 FY | 281.21 Million CNY | 49.87% |
| 2022 Q2 | 56.73 Million CNY | -46.55% |
| 2021 Q4 | 106.13 Million CNY | 30.21% |
| 2021 Q2 | 81.51 Million CNY | -41.03% |
| 2021 FY | 187.64 Million CNY | 21.8% |
| 2020 Q2 | 15.83 Million CNY | -87.04% |
| 2020 FY | 154.05 Million CNY | -8.09% |
| 2020 Q4 | 138.21 Million CNY | 772.67% |
| 2019 FY | 167.61 Million CNY | 64.03% |
| 2019 Q4 | 122.17 Million CNY | 168.91% |
| 2019 Q2 | 45.43 Million CNY | -38.2% |
| 2018 Q4 | 73.52 Million CNY | 156.5% |
| 2018 FY | 102.18 Million CNY | 66.48% |
| 2018 Q2 | 28.66 Million CNY | -30.17% |
| 2017 Q4 | 41.04 Million CNY | 101.86% |
| 2017 FY | 61.38 Million CNY | -40.36% |
| 2017 Q2 | 20.33 Million CNY | 91.04% |
| 2016 Q4 | 10.64 Million CNY | -88.46% |
| 2016 Q2 | 92.26 Million CNY | 42.86% |
| 2016 FY | 102.91 Million CNY | -33.44% |
| 2015 Q4 | 64.58 Million CNY | -28.26% |
| 2015 Q2 | 90.03 Million CNY | 31.26% |
| 2015 FY | 154.61 Million CNY | 26.85% |
| 2014 Q2 | 53.3 Million CNY | 75.18% |
| 2014 Q4 | 68.58 Million CNY | 28.68% |
| 2014 FY | 121.89 Million CNY | 74.34% |
| 2013 Q4 | 30.42 Million CNY | 0.0% |
| 2013 FY | 69.91 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 105.03 Million HKD | -138.161% |
| Grand Pharmaceutical Group Limited | 1.87 Billion HKD | 86.693% |
| Extrawell Pharmaceutical Holdings Limited | -162.94 Million HKD | 253.522% |
| Wai Yuen Tong Medicine Holdings Limited | -15.35 Million HKD | 1729.083% |
| Qianhai Health Holdings Limited | -52.7 Million HKD | 574.646% |
| Lee's Pharmaceutical Holdings Limited | 16.69 Million HKD | -1398.155% |
| Essex Bio-Technology Limited | 275.25 Million HKD | 9.118% |
| Tongfang Kontafarma Holdings Limited | -28.84 Million HKD | 967.323% |
| PuraPharm Corporation Limited | -106.08 Million HKD | 335.822% |
| SSY Group Limited | 1.31 Billion HKD | 81.028% |
| JBM (Healthcare) Limited | 130.46 Million HKD | -91.749% |
| Jacobson Pharma Corporation Limited | 266.96 Million HKD | 6.295% |
| China Resources Pharmaceutical Group Limited | 3.85 Billion HKD | 93.509% |